메뉴 건너뛰기




Volumn 26, Issue 1 II, 2003, Pages 332-337

Enhancement of J-ST-segment elevation by the glucose and insulin test in Brugada syndrome

Author keywords

Brugada syndrome; Glucose; Insulin; Pilsicainide; Potassium channel; Ventricular fibrillation

Indexed keywords

GLUCOSE; INSULIN; PILSICAINIDE; POTASSIUM;

EID: 0037247563     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2003.00044.x     Document Type: Conference Paper
Times cited : (68)

References (17)
  • 2
    • 0032879716 scopus 로고    scopus 로고
    • Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation
    • Yan GX, Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation 1999; 100:1660-1666.
    • (1999) Circulation , vol.100 , pp. 1660-1666
    • Yan, G.X.1    Antzelevitch, C.2
  • 3
    • 0029988521 scopus 로고    scopus 로고
    • Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome
    • Miyazaki T, Mitamura H, Miyoshi S, et al. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996; 27:1061-1070.
    • (1996) J Am Coll Cardiol , vol.27 , pp. 1061-1070
    • Miyazaki, T.1    Mitamura, H.2    Miyoshi, S.3
  • 4
    • 0030972925 scopus 로고    scopus 로고
    • Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease
    • Kasanuki H, Ohnishi S, Ohtuka M, et al. Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. Circulation 1997; 95:2227-2285.
    • (1997) Circulation , vol.95 , pp. 2227-2285
    • Kasanuki, H.1    Ohnishi, S.2    Ohtuka, M.3
  • 5
    • 0031795404 scopus 로고    scopus 로고
    • ST segment elevation induced by class IC antiarrhythmic agents: Underlying electrophysiologic mechanisms and insights into drug-induced proarrhythmia
    • Krishnan SC, Josephson ME. ST segment elevation induced by class IC antiarrhythmic agents: Underlying electrophysiologic mechanisms and insights into drug-induced proarrhythmia. J Cardiovasc Electrophysiol 1998; 9:1167-1172.
    • (1998) J Cardiovasc Electrophysiol , vol.9 , pp. 1167-1172
    • Krishnan, S.C.1    Josephson, M.E.2
  • 6
    • 0034063176 scopus 로고    scopus 로고
    • ST segment and T wave alternans in a patient with Brugada syndrome
    • Tada H, Nogami A, Shimizu W, et al. ST segment and T wave alternans in a patient with Brugada syndrome. PACE 2000; 23:413-415.
    • (2000) PACE , vol.23 , pp. 413-415
    • Tada, H.1    Nogami, A.2    Shimizu, W.3
  • 7
    • 0034548068 scopus 로고    scopus 로고
    • Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome
    • Shimizu W, Antzelevitch C, Suyama K, et al. Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. J Cardiovasc Electrophysiol 2000; 11:1320-1329.
    • (2000) J Cardiovasc Electrophysiol , vol.11 , pp. 1320-1329
    • Shimizu, W.1    Antzelevitch, C.2    Suyama, K.3
  • 8
    • 0034620574 scopus 로고    scopus 로고
    • Sodium channel blockers identify risk for sudden cardiac death in patients with ST-segment elevation and right bundle branch block but structurally normal heart
    • Brugada R, Brugada J, Antzelevitch C, et al. Sodium channel blockers identify risk for sudden cardiac death in patients with ST-segment elevation and right bundle branch block but structurally normal heart. Circulation 2000; 101:510-515.
    • (2000) Circulation , vol.101 , pp. 510-515
    • Brugada, R.1    Brugada, J.2    Antzelevitch, C.3
  • 9
    • 0033044699 scopus 로고    scopus 로고
    • The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome
    • Matsuo K, Kurita T, Inagaki M, et al. The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome. Eur Heart J 1999; 20:465-470.
    • (1999) Eur Heart J , vol.20 , pp. 465-470
    • Matsuo, K.1    Kurita, T.2    Inagaki, M.3
  • 10
    • 0031900307 scopus 로고    scopus 로고
    • Dynamic changes of 12-lead electrocardiograms in a patient with Brugada syndrome
    • Matsuo K, Shimizu W, Kurita T, et al. Dynamic changes of 12-lead electrocardiograms in a patient with Brugada syndrome. J Cardiovase Electrophysiol 1998; 9:508-512.
    • (1998) J Cardiovase Electrophysiol , vol.9 , pp. 508-512
    • Matsuo, K.1    Shimizu, W.2    Kurita, T.3
  • 11
    • 0033537470 scopus 로고    scopus 로고
    • "Brugada" syndrome: Clinical data and suggested pathophysiological mechanism
    • Aling M, Wilde A. "Brugada" syndrome: Clinical data and suggested pathophysiological mechanism. Circulation 1999; 99:666-673.
    • (1999) Circulation , vol.99 , pp. 666-673
    • Aling, M.1    Wilde, A.2
  • 13
    • 0028113918 scopus 로고
    • Effect of glibenclamide on ventricular fibrillation in non-insulin-dependent diabetics with acute myocardial infarction
    • Lomuscio A, Vergani D, Marano L, et al. Effect of glibenclamide on ventricular fibrillation in non-insulin-dependent diabetics with acute myocardial infarction. Coron Artery Dis 1994; 5:767-771.
    • (1994) Coron Artery Dis , vol.5 , pp. 767-771
    • Lomuscio, A.1    Vergani, D.2    Marano, L.3
  • 14
    • 0032160464 scopus 로고    scopus 로고
    • HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part II: Effects on susceptibility to ventrieular fibrillation induced by myocardialischemia in conscious dog
    • Billman GE, Englert HC, Scholkens BA. HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part II: Effects on susceptibility to ventrieular fibrillation induced by myocardialischemia in conscious dog. Pharmacology 1998; 286:1465-1473.
    • (1998) Pharmacology , vol.286 , pp. 1465-1473
    • Billman, G.E.1    Englert, H.C.2    Scholkens, B.A.3
  • 15
    • 0029664327 scopus 로고    scopus 로고
    • QTc duration is associated with levels of insulin and glucose intolerance. The Zutphen elderly study
    • Dekker JM, Feskens EJ, Schouten EG, et al. QTc duration is associated with levels of insulin and glucose intolerance. The Zutphen elderly study. Diabetes 1996; 45:376-380.
    • (1996) Diabetes , vol.45 , pp. 376-380
    • Dekker, J.M.1    Feskens, E.J.2    Schouten, E.G.3
  • 16
    • 0034113020 scopus 로고    scopus 로고
    • The effect of acute hyperglycemia on QTc duration in healthy man
    • Marfella R, Nappo F, De Angelis L, et al. The effect of acute hyperglycemia on QTc duration in healthy man. Diabetologia 2000; 43:571-575.
    • (2000) Diabetologia , vol.43 , pp. 571-575
    • Marfella, R.1    Nappo, F.2    De Angelis, L.3
  • 17
    • 0036242345 scopus 로고    scopus 로고
    • Effects of glucose-induced insulin secretion on ventricular repolarization in patients with congenital long QT syndrome
    • Nishizaki M, Ashikawa T, Yamakawa N, et al. Effects of glucose-induced insulin secretion on ventricular repolarization in patients with congenital long QT syndrome. Circ J 2002; 66:35-40.
    • (2002) Circ J , vol.66 , pp. 35-40
    • Nishizaki, M.1    Ashikawa, T.2    Yamakawa, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.